文献速递病毒性肝炎

肝细胞来源左卡尼汀抑制生发中心免疫细胞延缓HBsAg清除

Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells.
PubMed 文献 · J Infect Dis · 2022-01-01

该研究通过体外实验、HBV小鼠模型及慢性HBV感染者样本,探讨左卡尼汀(L-Cn)对生发中心(GC)相关免疫细胞的影响。发现L-Cn可抑制GC相关免疫反应、增强免疫抑制特征,小鼠中给予L-Cn延迟血清HBsAg清除并减少脾脏GC形成;HBsAg清除患者血浆L-Cn水平降低,低基线L-Cn与有利治疗应答相关。提示肝细胞来源L-Cn可能通过免疫抑制参与慢性HBV感染中HBsAg清除障碍。

要点

  • L-Cn抑制生发中心相关免疫反应并增强免疫抑制特征
  • 小鼠模型中给予L-Cn延迟血清HBsAg清除并减少脾脏GC形成
  • HBsAg清除者血浆L-Cn降低,低基线L-Cn与有利治疗应答相关

核心结论

  • 肝细胞来源L-Cn对GC相关免疫细胞的抑制作用可能参与慢性HBV感染中HBsAg清除障碍。
  • L-Cn可能作为HBV感染治疗的潜在靶点。

研究设计与样本

  • 研究在慢性HBV感染患者及流体动力学注射小鼠模型中进行体外和体内实验。

主要发现

  • 体外实验显示L-Cn显著降低GC相关免疫反应并增强免疫抑制特征。
  • 裂解肝细胞释放的L-Cn与肝损伤程度相关。
  • HBV小鼠模型中给予L-Cn导致血清HBsAg清除延迟并减少脾脏GC形成。
  • HBsAg清除患者血浆L-Cn水平降低。
  • 纵向观察发现低基线L-Cn水平与慢性乙型肝炎患者有利治疗应答相关。

临床怎么用

  • L-Cn可能作为慢性HBV感染中促进HBsAg清除的潜在干预靶点。
  • 基线L-Cn水平或可用于提示慢性乙型肝炎患者的治疗应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The outcome of hepatitis B virus (HBV) infection is significantly affected by host immune response; herein, we aim to dissect the effect of L-carnitine (L-Cn) on germinal center (GC)-related immune cells and the influence on the prognosis of HBV infection. METHODS: In vitro and in vivo experiments were performed in patients with chronic HBV infection and a hydrodynamic injection mouse model. RESULTS: In vitro assays revealed that L-Cn significantly reduced GC-related immune responses and enhanced immunosuppressive profiles. Intriguingly, L-Cn released from lysed hepatocytes was associated with the degree of liver damage. Besides, the administration of L-Cn in an HBV mouse model resulted in delayed clearance of hepatitis B surface antigen (HBsAg) in serum and decreased GC formation in the spleen. Notably, patients with HBsAg loss showed decreased plasma L-Cn levels, and longitudinal observations found that low baseline levels of L-Cn were associated with a favorable treatment response in patients with chronic hepatitis B. CONCLUSIONS: The suppressive effect of hepatocyte-derived L-Cn on GC-related immune cells may contribute to the inability of HBsAg clearance in chronic HBV infection, indicating that L-Cn might serve as a potential therapeutic target for the treatment of HBV infection.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gu S, Wang W, Ye G, et al. Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells. J Infect Dis. 2022. PMID: 34214150. doi:10.1093/infdis/jiab344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。